Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.
Annika RösslerAntonia NetzlLudwig KnablSamuel H WilksBarbara MühlemannSina TüreliAnna MykytynDorothee von LaerBart L HaagmansDerek J SmithJanine KimpelPublished in: NPJ vaccines (2024)
Antigenic characterization of newly emerging SARS-CoV-2 variants is important to assess their immune escape and judge the need for future vaccine updates. To bridge data obtained from animal sera with human sera, we analyzed neutralizing antibody titers in human and hamster single infection sera in a highly controlled setting using the same authentic virus neutralization assay performed in one laboratory. Using a Bayesian framework, we found that titer fold changes in hamster sera corresponded well to human sera and that hamster sera generally exhibited higher reactivity.